Serum Resistin and High Sensitive CRP Levels in Patients with Subclinical Hypothyroidism Before and After L-thyroxine Therapy

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2013 Mar 23

PMID 23518675

Citations 16

Authors

Duygu Yazgan Aksoy

Nese Cinar

Ayla Harmanci

Jale Karakaya

Bulent Okan Yildiz

Aydan Usman

Miyase Bayraktar

Affiliations

Soon will be listed here.

Abstract

Background: Subclinical hypothyroidism (SH) is defined by increased thyrotropin (TSH) and normal free thyroxine (fT4) and free triiodothyronine (fT3) levels. Resistin is secreted from adipose tissue and is reported to be associated with insulin resistance and/or inflammation. High sensitive CRP (hs-CRP) is a reliable marker of inflammation. Data related to levels of resistin and hs-CRP in SH and the effect of L-thyroxine treatment on those is limited. We aimed to determine the levels of resistin and hs-CRP in women with SH, and potential effects of L-thyroxine therapy on those levels.

Material And Methods: Thirty-six patients with SH and 27 age- and BMI-matched healthy control women were included. Waist circumference (Wc), waist-to-hip ratio (WHR), resting energy expenditure (REE), fat mass (FM) and lean mass (LM), TSH, free T4 (fT4), free T3 (fT3), total cholesterol (TC), triglycerides (TG), and HDL- and LDL-cholesterol were determined in all participants. Patients received L-thyroxine treatment for 6 months, after which all measurements were repeated. Resistin and hs-CRP levels were studied from frozen samples after the completion of the study.

Results: The 2 groups had similar values for Wc, WHR, FM, LM, TC, TG, HDL-C, LDL-C, resistin, and hs-CRP at the beginning. fT4 were higher, whereas TSH was lower in the control group. Resistin and hs-CRP levels did not change after treatment. hs-CRP correlated with BMI and FM before and after treatment.

Conclusions: Our results suggest that achievement of euthyroid status by replacement therapy did not change resistin or hs-CRP levels in women with SH. hs-CRP correlated with parameters of obesity, which emphasizes the role of body weight in inflammation.

Citing Articles

Metabolic Consequences of Thyroidectomy and Patient-Centered Management.

Wang K, Gulec S J Clin Med. 2024; 13(23).

PMID: 39685923 PMC: 11642069. DOI: 10.3390/jcm13237465.

Dyslipidaemia and inflammatory markers as the risk predictors for cardiovascular disease in newly diagnosed premenopausal hypothyroid women.

Balamurugan V, Maradi R, Joshi V, Shenoy B, Goud M J Med Biochem. 2023; 42(1):58-66.

PMID: 36819139 PMC: 9920932. DOI: 10.5937/jomb0-37007.

Association between circulating resistin levels and thyroid dysfunction: A systematic review and meta-analysis.

Zhou L, Song K, Luo W Front Endocrinol (Lausanne). 2023; 13:1071922.

PMID: 36686437 PMC: 9845899. DOI: 10.3389/fendo.2022.1071922.

Causal Association of Thyroid Signaling with C-Reactive Protein: A Bidirectional Mendelian Randomization.

Li T, Geng H, Wang Y, Wu Z, Yang S, Hu Y Comput Math Methods Med. 2022; 2022:8954606.

PMID: 35996695 PMC: 9392607. DOI: 10.1155/2022/8954606.

Left and right ventricular functions may be impaired in children diagnosed with subclinical hypothyroidism.

Akin A, Unal E, Yildirim R, Ture M, Balik H, Kenan Haspolat Y Sci Rep. 2020; 10(1):19711.

PMID: 33184320 PMC: 7661521. DOI: 10.1038/s41598-020-76327-4.

References

Krassas G, Pontikides N, Loustis K, Koliakos G, Constantinidis T, Kaltsas T . Resistin levels are normal in hypothyroidism and remain unchanged after attainment of euthyroidism: relationship with insulin levels and anthropometric parameters. J Endocrinol Invest. 2006; 29(7):606-12. DOI: 10.1007/BF03344159. View

Stepien M, Rosniak-Bak K, Paradowski M, Misztal M, Kujawski K, Banach M . Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results. Med Sci Monit. 2011; 17(11):PR13-18. PMC: 3539504. DOI: 10.12659/msm.882030. View

Bourlier V, Bouloumie A . Role of macrophage tissue infiltration in obesity and insulin resistance. Diabetes Metab. 2009; 35(4):251-60. DOI: 10.1016/j.diabet.2009.05.001. View

Bossowski A, Sawicka B, Szalecki M, Koput A, Wysocka J, Zelazowska-Rutkowska B . Analysis of serum adiponectin, resistin and leptin levels in children and adolescents with autoimmune thyroid disorders. J Pediatr Endocrinol Metab. 2010; 23(4):369-77. DOI: 10.1515/jpem.2010.058. View

Kim M, Small C, Stanley S, Morgan D, Seal L, Kong W . The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest. 2000; 105(7):1005-11. PMC: 377483. DOI: 10.1172/JCI8857. View

Patel S, Rajala M, Rossetti L, Scherer P, Shapiro L . Disulfide-dependent multimeric assembly of resistin family hormones. Science. 2004; 304(5674):1154-8. DOI: 10.1126/science.1093466. View

Flier J . Clinical review 94: What's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab. 1998; 83(5):1407-13. DOI: 10.1210/jcem.83.5.4779. View

Filkova M, Haluzik M, Gay S, Senolt L . The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol. 2009; 133(2):157-70. DOI: 10.1016/j.clim.2009.07.013. View

Nannipieri M, Cecchetti F, Anselmino M, Camastra S, Niccolini P, Lamacchia M . Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int J Obes (Lond). 2009; 33(9):1001-6. DOI: 10.1038/ijo.2009.140. View

10.

Unek I, Bayraktar F, Solmaz D, Ellidokuz H, Yuksel F, Sisman A . Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome. Metabolism. 2009; 59(3):305-13. DOI: 10.1016/j.metabol.2009.04.034. View

11.

Chiamolera M, Wondisford F . Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology. 2009; 150(3):1091-6. DOI: 10.1210/en.2008-1795. View

12.

Hueston W, King D, Geesey M . Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism. Clin Endocrinol (Oxf). 2005; 63(5):582-7. DOI: 10.1111/j.1365-2265.2005.02388.x. View

13.

Toruner F, Altinova A, Karakoc A, Yetkin I, Ayvaz G, Cakir N . Risk factors for cardiovascular disease in patients with subclinical hypothyroidism. Adv Ther. 2008; 25(5):430-7. DOI: 10.1007/s12325-008-0053-7. View

14.

Utzschneider K, Carr D, Tong J, Wallace T, Hull R, Zraika S . Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia. 2005; 48(11):2330-3. DOI: 10.1007/s00125-005-1932-y. View

15.

Harsch I, Koebnick C, Wallaschofski H, Schahin S, Hahn E, Ficker J . Resistin levels in patients with obstructive sleep apnoea syndrome--the link to subclinical inflammation?. Med Sci Monit. 2004; 10(9):CR510-5. View

16.

Koerner A, Kratzsch J, Kiess W . Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come. Best Pract Res Clin Endocrinol Metab. 2005; 19(4):525-46. DOI: 10.1016/j.beem.2005.07.008. View

17.

Cooper D . Clinical practice. Subclinical hypothyroidism. N Engl J Med. 2001; 345(4):260-5. DOI: 10.1056/NEJM200107263450406. View

18.

Krecki R, Krzeminska-Pakula M, Peruga J, Szczesniak P, Lipiec P, Wierzbowska-Drabik K . Elevated resistin opposed to adiponectin or angiogenin plasma levels as a strong, independent predictive factor for the occurrence of major adverse cardiac and cerebrovascular events in patients with stable multivessel coronary artery disease over.... Med Sci Monit. 2010; 17(1):CR26-32. PMC: 3524681. DOI: 10.12659/msm.881325. View

19.

Krassas G, Pontikides N, Loustis K, Koliakos G, Constantinidis T, Panidis D . Resistin levels in hyperthyroid patients before and after restoration of thyroid function: relationship with body weight and body composition. Eur J Endocrinol. 2005; 153(2):217-21. DOI: 10.1530/eje.1.01963. View

20.

Kaplan O, Uzum A, Aral H, Uzum G, Tunali V, Demir O . Unchanged serum adipokine concentrations in the setting of short-term thyroidectomy-induced hypothyroidism. Endocr Pract. 2012; 18(6):887-93. DOI: 10.4158/EP12001.OR. View